Up Next
-
Part 2 | Session 1 Session 2.1: Strategies for Calcified Coronary Lesions Anno 2022
-
Part 2 | Session 2 Session 2.2: Live Cases and Discussion
-
Part 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme
-
Part 2 | Session 5 Session 2.4: Live Cases and Discussion
-
Part 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How?
-
Part 3 | Session 1 Session 3.1 & 3.2: Keynote & Controversies
-
Part 3 | Session 2 Session 3.3: Live Cases and Discussion
-
Part 3 | Session 4 Session 3.4: Debates
-
Part 1 | Session 1 Session 1.1: Next Level Structural Heart Interventions
-
Part 1 | Session 2 Session 1.2: Live Cases and Discussion
-
Part 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI
-
Part 1 | Session 5 Session 1.4: Live Cases and Discussions
-
Part 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC
Overview
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Transcatheter Interventions Online 2022 was supported by the following partners:

Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2